MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas.

BACKGROUND There are limited predictors of prognosis in patients with clinically non-functioning pituitary adenomas (NFPAs). We hypothesized that MRI texture analysis may predict tumor recurrence or progression in patients with NFPAs undergoing transsphenoidal pituitary surgery (TSS). OBJECTIVE To characterize texture parameters on preoperative MRI examinations in patients with NFPAs in relation to prognosis. METHODS Retrospective study of patients with NFPAs who underwent TSS at our institution between 2009 and 2010. Clinical, radiological and histopathological data were extracted from electronic medical records. MRI texture analysis was performed on coronal T1-weighted non-enhanced MR images using ImageJ (NIH). MRI texture parameters were used to predict tumor recurrence or progression. Both logistic regression and Cox proportional hazard analyses were conducted to adjust for potential confounders. RESULTS Data on 78 patients were analyzed. On both crude and multivariable-adjusted analyses, mean, median, mode, minimum and maximum pixel intensity were associated with the risk of pituitary tumor recurrence or progression after TSS. Patients whose tumor mean pixel intensity was above the median for the population had a hazard ratio of 0.44 (95% CI: 0.21-0.94, P = 0.034) for recurrence or progression in comparison with tumors below the median. CONCLUSIONS Our data suggest that MRI texture analysis can predict the risk of tumor recurrence or progression in patients with NFPAs.

[1]  M. P. Hayball,et al.  CT texture analysis using the filtration-histogram method: what do the measurements mean? , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[2]  Victor M Montori,et al.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[3]  M. Losa,et al.  Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. , 2008, Journal of neurosurgery.

[4]  B. Swearingen.  Update on pituitary surgery. , 2012, The Journal of clinical endocrinology and metabolism.

[5]  Balaji Ganeshan,et al.  Quantifying tumour heterogeneity with CT , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[6]  V. Goh,et al.  Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. , 2013, Radiology.

[7]  B. Scheithauer,et al.  MGMT immunoexpression in aggressive pituitary adenoma and carcinoma , 2010, Pituitary.

[8]  Alberto Fernández,et al.  Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK) , 2010, Clinical endocrinology.

[9]  C. Good,et al.  Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade , 2012, Journal of Neuro-Oncology.

[10]  C. Chatwin,et al.  Dynamic Contrast-Enhanced Texture Analysis of the Liver: Initial Assessment in Colorectal Cancer , 2011, Investigative radiology.

[11]  L. Behan,et al.  The natural history of surgically treated but radiotherapy‐naïve nonfunctioning pituitary adenomas , 2009, Clinical endocrinology.

[12]  Ferdinand Roelfsema,et al.  Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis , 2011, Pituitary.

[13]  Balaji Ganeshan,et al.  Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. , 2009, Radiology.

[14]  V. Goh,et al.  Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. , 2013, Radiology.

[15]  J. Hardy,et al.  The clinical and endocrine outcome to trans‐sphenoidal microsurgery of nonsecreting pituitary adenomas , 1991, Cancer.

[16]  K. Miles,et al.  Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. , 2012, Clinical radiology.

[17]  P. Freda,et al.  Differential diagnosis of sellar masses. , 1999, Endocrinology and metabolism clinics of North America.

[18]  E. Laws,et al.  The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. , 2002, Journal of neurosurgery.

[19]  M. Molitch.  Nonfunctioning pituitary tumors and pituitary incidentalomas. , 2008, Endocrinology and metabolism clinics of North America.

[20]  B. Scheithauer,et al.  Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. , 1996, Neurosurgery.

[21]  Odelia Cooper,et al.  Silent corticotroph adenomas , 2018, Pituitary.

[22]  F. Cendes,et al.  Texture analysis of medical images. , 2004, Clinical radiology.

[23]  Bal Sanghera,et al.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.

[24]  G. Tourassi.  Journey toward computer-aided diagnosis: role of image texture analysis. , 1999, Radiology.

[25]  A. Beckers,et al.  High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. , 2006, The Journal of clinical endocrinology and metabolism.

[26]  M. Fleseriu,et al.  Silent somatotroph pituitary adenomas: an update , 2018, Pituitary.

[27]  K. Miles,et al.  Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival , 2012, European Radiology.

[28]  X. Bertagna,et al.  Influence of radiotherapy on long-term relapse in clinically non-secreting pituitary adenomas. A retrospective study (1970-1988). , 1993, The European journal of medicine.

[29]  Michael Buchfelder,et al.  Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. , 2007, European journal of endocrinology.

[30]  N. Karavitaki,et al.  Do the limits of serum prolactin in disconnection hyperprolactinaemia need re‐definition? A study of 226 patients with histologically verified non‐functioning pituitary macroadenoma , 2006, Clinical endocrinology.

[31]  P. Chanson,et al.  Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. , 2010, European journal of endocrinology.

[32]  J.R. Mitchell,et al.  MRI Texture Analysis Predicts p53 Status in Head and Neck Squamous Cell Carcinoma , 2015, American Journal of Neuroradiology.